30 results on '"Twohig, Helen"'
Search Results
2. Applying the consolidated framework for implementation research to evaluate the community rapid intervention service
- Author
-
Moult, Alice, Baker, Dereth, Twohig, Helen, Missen, Matthew, Iqbal, Zafar, Duffy, Helen, and Paskins, Zoe
- Published
- 2023
- Full Text
- View/download PDF
3. Development and psychometric evaluation of a patient reported outcome measure for polymyalgia rheumatica
- Author
-
Twohig, Helen Jane, Muller, S. N., Mitchell, Caroline, and Mallen, C. D.
- Subjects
R Medicine (General) - Abstract
Background: Polymyalgia rheumatica (PMR) causes pain, stiffness and disability in older adults. Measuring the impact of the condition from the patient's perspective is vital to highquality research and patient-centred care, yet there are no validated patient reported outcome measures (PROMs) for PMR. The aims of this PhD are, i) to identify outcome measures and instruments used in clinical studies of PMR and evaluate the evidence supporting their use in the condition, and ii) to develop and evaluate a PMR-specific PROM. Methods: Outcomes and instruments used in PMR research were systematically identified and categorised. Studies on their measurement properties were appraised. Two primary research studies were then undertaken: 1) 256 people with PMR completed a draft PROM providing data for item reduction, formation of dimension structure and scoring system development. 2) 179 people with PMR completed the PROM at two time points along with comparator questionnaires and anchor questions. Test-retest reliability, construct validity, and responsiveness were evaluated. Results: The most frequent outcomes (and instruments) identified in the literature were: markers of systemic inflammation (ESR/CRP), pain (visual analogue scale), stiffness (duration) and physical function (elevation of upper limbs). No instruments had high-quality evidence to support their use in PMR. Results from the first study led to the development of a PROM, the PMR-impact scale (PMR-IS), comprising symptoms, function, emotional and psychological well-being and steroid side-effects domains. Construct validity and test-retest reliability were good for each domain of the PMR-IS. It was responsive to improvement in the condition but there was insufficient evidence to determine its ability to detect flares. Conclusions: Current outcome measures used in PMR are not adequate. The PMR-IS provides a real opportunity to improve patient centred research and care, but further work is needed to more fully establish its responsiveness and interpretability parameters.
- Published
- 2022
4. Test-retest reliability of pain VAS/NRS, stiffness VAS/NRS, HAQ-DI and mHAQ in polymyalgia rheumatica: An OMERACT study
- Author
-
Leung, Jessica L., Twohig, Helen, Muller, Sara, Maxwell, Lara, Mackie, Sarah L., Neill, Lorna M, and Owen, Claire E.
- Published
- 2023
- Full Text
- View/download PDF
5. Analgesic prescribing in patients with inflammatory arthritis in England: observational studies in the Clinical Practice Research Datalink.
- Author
-
Scott, Ian C, Whittle, Rebecca, Bailey, James, Twohig, Helen, Hider, Samantha L, Mallen, Christian D, Muller, Sara, and Jordan, Kelvin P
- Subjects
CROSS-sectional method ,NONSTEROIDAL anti-inflammatory agents ,PSORIATIC arthritis ,RESEARCH funding ,RHEUMATOID arthritis ,SCIENTIFIC observation ,ANKYLOSIS ,DISEASE prevalence ,DESCRIPTIVE statistics ,ANALGESICS ,PHYSICIAN practice patterns ,OPIOID analgesics ,GABAPENTIN ,PAIN management ,DRUG prescribing ,SPONDYLOARTHROPATHIES ,CONFIDENCE intervals ,REGRESSION analysis ,PROPORTIONAL hazards models - Abstract
Objectives Despite little evidence that analgesics are effective in inflammatory arthritis (IA), studies report substantial opioid prescribing. The extent this applies to other analgesics is uncertain. We undertook a comprehensive evaluation of analgesic prescribing in patients with IA in the Clinical Practice Research Datalink Aurum to evaluate this. Methods From 2004 to 2020, cross-sectional analyses evaluated analgesic prescription annual prevalence in RA, PsA and axial spondyloarthritis (axSpA), stratified by age, sex, ethnicity, deprivation and geography. Joinpoint regression evaluated temporal prescribing trends. Cohort studies determined prognostic factors at diagnosis for chronic analgesic prescriptions using Cox proportional hazards models. Results Analgesic prescribing declined over time but remained common: 2004 and 2020 IA prescription prevalence was 84.2/100 person-years (PY) (95% CI 83.9, 84.5) and 64.5/100 PY (64.2, 64.8), respectively. In 2004, NSAIDs were most prescribed (56.1/100 PY; 55.8, 56.5), falling over time. Opioids were most prescribed in 2020 (39.0/100 PY; 38.7, 39.2). Gabapentinoid prescribing increased: 2004 prevalence 1.1/100 PY (1.0, 1.2); 2020 prevalence 9.9/100 PY (9.7, 10.0). Most opioid prescriptions were chronic (2020 prevalence 23.4/100 PY [23.2, 23.6]). Non-NSAID analgesic prescribing was commoner in RA, older people, females and deprived areas/northern England. Conversely, NSAID prescribing was commoner in axSpA/males, varying little by deprivation/geography. Peri-diagnosis was high-risk for starting chronic opioid/NSAID prescriptions. Prognostic factors for chronic opioid/gabapentinoid and NSAID prescriptions differed, with NSAIDs having no consistently significant association with deprivation (unlike opioids/gabapentinoids). Conclusion IA analgesic prescribing of all classes is widespread. This is neither evidence-based nor in line with guidelines. Peri-diagnosis is an opportune moment to reduce chronic analgesic prescribing. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Coproducing Health Information Materials With Young People: Reflections and Lessons Learned.
- Author
-
Faux‐Nightingale, Alice, Somayajula, Glenys, Bradbury, Charlotte, Bray, Lucy, Burton, Claire, Chew‐Graham, Carolyn A., Gardner, Aaliyah, Griffin, Alex, Twohig, Helen, and Welsh, Victoria
- Subjects
HEALTH information services ,SOCIAL media ,AUDIOVISUAL materials ,PAMPHLETS ,INTERPROFESSIONAL relations ,RESEARCH funding ,DIFFUSION of innovations ,HUMAN services programs ,POST-acute COVID-19 syndrome ,TEACHING aids ,SCHOOLS ,EDUCATIONAL outcomes ,INFORMATION resources ,REFLECTION (Philosophy) ,ETHICS ,MATHEMATICAL models ,CONCEPTUAL structures ,VIDEOCONFERENCING ,PROBLEM-based learning ,HEALTH education ,THEORY ,STAKEHOLDER analysis ,MEDICINE information services ,PATIENT participation ,ACCESS to information - Abstract
Background: This paper describes and critically reflects on how children and young people (CYP) acted as public advisors to coproduce health information materials about Long Covid for younger audiences. This work was underpinned by the Lundy model, a framework which provides guidance on facilitating CYP to actively contribute to matters which affect them. Methods: Coproduction activity sessions took place with CYP in schools as well as video conferences with a CYP stakeholder group and CYP with Long Covid. Activities encouraged CYP to focus on the content, format, and design of materials and used problem‐based and collaborative learning to encourage engagement with the project. Using a range of methods and open discussion, CYP codesigned a series of Long Covid health information materials for younger audiences. Results: Sixty‐six CYP (aged 10–18), and two young adults were involved. CYP codesigned specifications for the final materials and provided feedback on early designs. The project led to the development of a series of health information materials targeted at CYP: a short social media campaign with six short videos and a 12‐page illustrated leaflet about Long Covid; released on social media and distributed in local area. All the CYP were positive about the project and their involvement. Discussion: Involving CYP led to the development of innovative and engaging information materials (influence). Developing rapport was important when working with CYP and this was facilitated by using approaches and activities to establish an environment (space) where the CYP felt comfortable sharing their views (voice) and being listened to (audience) by the adults in the project. Working with external groups who are willing to share their expertise can help the meaningful involvement of voices 'less heard'. Public Contribution: One CYP coapplicant contributed to the project design and facilitation of PPIE sessions, 64 CYP were involved in the PPIE sessions to design and feedback on materials. Two young adult media producers worked with CYP to produce these materials, another CYP supported this process. Three public contributors were involved in the preparation of this manuscript. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Experiences and care needs of children with long COVID: a qualitative study.
- Author
-
Faux-Nightingale, Alice, Saunders, Benjamin, Burton, Claire, Chew-Graham, Carolyn A., Somayajula, Glenys, Twohig, Helen, and Welsh, Victoria
- Subjects
QUALITATIVE research ,RESEARCH funding ,FOCUS groups ,POST-acute COVID-19 syndrome ,HEALTH ,INTERVIEWING ,PATIENT care ,PARENT attitudes ,FAMILIES ,UNCERTAINTY ,HELP-seeking behavior ,DESCRIPTIVE statistics ,EXPERIENCE ,LONGITUDINAL method ,THEMATIC analysis ,ATTITUDES of medical personnel ,QUALITY of life ,RESEARCH methodology ,NEEDS assessment ,INTERPERSONAL relations ,COMPARATIVE studies ,PATIENTS' attitudes ,WELL-being ,DISEASE complications ,CHILDREN - Abstract
Background: Long COVID, the patient-preferred term, describes symptoms persisting after an acute episode of COVID-19 infection. Symptoms in children and young people (CYP) can affect daily routine, with broader impacts on education, health-related quality of life, and social activities, which may have long-term effects on health and wellbeing. Aim: To explore the lived experiences and care needs of CYP with long COVID from the perspectives of CYP with long COVID, their parents, and professionals associated with the care of children and families living with the condition. Design & setting: CYP and their parent or carer were invited for interview following participation in a cohort study, which recruited the sample from a primary care setting. Method: Interviews were carried out with four CYP with long COVID (all female, aged 10-17 years); three interviews included a parent. Two focus groups were conducted, which included seven professionals involved with care of CYP or long COVID, from a range of disciplines. Interviews and focus groups were transcribed verbatim, and data analysed thematically using constant comparison techniques. Results: The three main themes presented are as follows: living with long COVID; uncertainty surrounding long COVID; and seeking help for symptoms. Conclusion: Long COVID can severely impact the lives of CYP and their families. CYP and their families need to be listened to by professionals and have any uncertainties acknowledged. It is imperative that agencies working with them understand the condition and its impact, and are able to offer support where needed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope.
- Author
-
Toyoda, Task, Armitstead, Zoe, Bhide, Sampada, Engamba, Serge, Henderson, Emma, Jones, Claire, MacKeith, Pieter, Maddock, Janice, Reynolds, Gary, Scrafton, Nicola, Subesinghe, Manil, Subesinghe, Sujith, Twohig, Helen, Mackie, Sarah L, and Yates, Max
- Subjects
POLYMYALGIA rheumatica ,RHEUMATISM treatment ,RHEUMATOLOGY - Abstract
The last British Society for Rheumatology (BSR) guideline on PMR was published in 2009. The guideline needs to be updated to provide a summary of the current evidence for pharmacological and non-pharmacological management of adults with PMR. This guideline is aimed at healthcare professionals in the UK who directly care for people with PMR, including general practitioners, rheumatologists, nurses, physiotherapists, occupational therapists, pharmacists, psychologists and other health professionals. It will also be relevant to people living with PMR and organisations that support them in the public and third sector, including charities and informal patient support groups. This guideline will be developed using the methods and processes outlined in the BSR Guidelines Protocol. Here we provide a brief summary of the scope of the guideline update in development. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. A Scoping Review of the Effects of Ambient Air Quality on Cognitive Frailty.
- Author
-
Hodgson, James Robert, Benkowitz, Charlotte, Castellani, Brian C., Ellison, Amanda, Yassaie, Rammina, Twohig, Helen, Bhudia, Roshni, Jutila, Otto-Emil Ilmari, and Fowler-Davis, Sally
- Subjects
AIR quality ,FRAILTY ,SOCIOECONOMIC disparities in health ,LITERATURE reviews ,AIR pollution - Abstract
Environmental and public health research has given considerable attention to the impact of air quality on brain health, with systematic reviews being widespread. No literature review has been conducted for cognitive frailty—a multidimensional syndrome combining physical frailty and cognitive impairment and their apparent co-dependence, linked to increased vulnerability and adverse health outcomes, including dementia. Instead, cognitive decline and frailty are implicitly explored through research on air quality and comorbid cognitive and physical decline in elderly populations. A scoping review was conducted to explore the need for a systematic review. Combining the Arksey and O'Malley, and PRISMA-ScR checklist, a scoping review of SCOPUS using 'cogniti*' + 'resilience' + 'air quality' or 'cogniti*' + 'ageing' + 'air quality' resulted in n = 2503 articles, screened and reduced using inclusion and exclusion criteria, to n = 16 articles. Air quality appears to be a critical risk factor for cognitive decline, even at air quality levels below WHO targets. Moderate long-term ambient air pollution appears linked to increased risk of cognitive frailty, suggesting earlier and more active interventions to protect older people. There are varied effects on cognition across the life course, with both emotional and functional impacts. Effects may be more detrimental to elderly people with existing conditions, including economic and health inequalities. Generalisation of results is limited due to the absence of a dose–response, variations in methods, controlling for comorbid effects, and variance across studies. No literature review has been performed for cognitive frailty, largely due to the fact that it is not presently treated as an explicit outcome. The findings support the need for more research and a more extensive summary of the literature but suggest that there is worsening cognitive function over the life course as a result of increased PM
2.5 concentrations. Furthermore, air quality appears to be a critical risk factor even at levels below World Health Organisation targets. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
10. Symptom patterns and life with post-acute COVID-19 in children aged 8-17 years: a mixed-methods study protocol.
- Author
-
Faux-Nightingale, Alice, Burton, Claire, Twohig, Helen, Blagojevic-Bucknall, Milica, Carroll, Will, Chew-Graham, Carolyn A., Dunn, Kate, Gilchrist, Francis, Helliwell, Toby, Lawton, Oliver, Lawton, Sarah, Mallen, Christian, Saunders, Benjamin, van der Windt, Danielle, and Welsh, Victoria
- Subjects
COVID-19 ,PATIENT participation ,POST-acute COVID-19 syndrome ,QUALITY of life ,VACCINATION status ,MEDICAL needs assessment ,CHILDREN ,ADOLESCENCE - Abstract
Background: While there is a substantial body of knowledge about acute COVID-19, less is known about long-COVID, where symptoms continue beyond 4 weeks. Aim: To describe longer-term effects of COVID-19 infection in children and young people (CYP) and identify their needs in relation to long-COVID. Design & setting: This study comprises an observational prospective cohort study and a linked qualitative study, identifying participants aged 8-17 years in the West Midlands of England. Method: CYP will be invited to complete online questionnaires to monitor incidences and symptoms of COVID-19 over a 12-month period. CYP who have experienced long-term effects of COVID will be invited to interview, and those currently experiencing symptoms will be asked to document their experiences in a diary. Professionals who work with CYP will be invited to explore the impact of long-COVID on the wider experiences of CYP, in a focus group. Descriptive statistics will be used to describe the incidence and rates of resolution of symptoms, and comparisons will be made between exposed and non-exposed groups. Logistic regression models will be used to estimate associations between candidate predictors and the development of long-COVID, and linear regression will be used to estimate associations between candidate predictors. Qualitative data will be analysed thematically using the constant comparison method. Conclusion: This study will describe features and symptoms of long-COVID and explore the impact of long-COVID within the lives of CYP and their families, to provide better understanding of long-COVID and inform clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. “I suddenly felt I’d aged”: A qualitative study of patient experiences of polymyalgia rheumatica (PMR)
- Author
-
Twohig, Helen, Mitchell, Caroline, Mallen, Christian, Adebajo, Adewale, and Mathers, Nigel
- Published
- 2015
- Full Text
- View/download PDF
12. Development and psychometric evaluation of the PMR-Impact Scale: a new patient reported outcome measure for polymyalgia rheumatica.
- Author
-
Twohig, Helen, Mitchell, Caroline, Mallen, Christian D, and Muller, Sara
- Subjects
- *
RESEARCH , *STATISTICS , *WELL-being , *CLINICAL deterioration , *STATISTICAL reliability , *CROSS-sectional method , *STEROIDS , *HEALTH outcome assessment , *PATIENT-centered care , *PSYCHOMETRICS , *SURVEYS , *MULTITRAIT multimethod techniques , *POLYMYALGIA rheumatica , *FACTOR analysis , *QUESTIONNAIRES , *DATA analysis , *EMOTIONS - Abstract
Objectives PMR causes pain, stiffness and disability in older adults. Measuring the impact of the condition from the patient's perspective is vital to high-quality research and patient-centred care, yet there are no validated patient-reported outcome measures (PROMs) for PMR. We set out to develop and psychometrically evaluate a PMR-specific PROM. Methods Two cross-sectional postal surveys of people with a confirmed diagnosis of PMR were used to provide data for field testing and psychometric evaluation. A total of 256 participants completed the draft PROM. Distribution of item responses was examined, and exploratory factor analysis and Rasch analysis were used to inform item reduction, formation of dimension structure and scoring system development. Some 179 participants completed the PROM at two time points, along with comparator questionnaires and anchor questions. Test–retest reliability, construct validity and responsiveness were evaluated. Results Results from the field-testing study led to the formation of the PMR-Impact Scale (PMR-IS), comprising four domains (symptoms, function, psychological and emotional well-being, and steroid side effects). Construct validity and test–retest reliability met accepted quality criteria for each domain. There was insufficient evidence from this study to determine its ability to detect flares/deterioration, but the PMR-IS was responsive to improvements in the condition. Conclusion The PMR-IS offers researchers a new way to assess patient-reported outcomes in clinical studies of PMR. It has been developed robustly, with patient input at every stage. It has good construct validity and test–retest reliability. Further work is needed to fully establish its responsiveness and interpretability parameters, and to assess its real-world clinical utility. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Chronic kidney disease in elderly people: disease or disease label?
- Author
-
Ellam, Timothy, Twohig, Helen, and Khwaja, Arif
- Published
- 2016
- Full Text
- View/download PDF
14. Feasibility and face validity of outcome measures for use in future studies of Polymyalgia Rheumatica (PMR): An OMERACT Study
- Author
-
Yates, Max, Owen, Claire E, Muller, Sara, Graham, Karly, Neill, Lorna, Twohig, Helen, Boers, Maarten, Pujades Rodriguez, Mar, Goodman, Susan, Cheah, Jonathan, Dejaco, Christian, Mukhtyar, Chetan, Nielsen, Berit Dalsgaard, Robson, Joanna, Simon, Lee S, Shea, Beverley, Mackie, Sarah L, Hill, Catherine L, Owen, Claire E., Goodman, Susan M., Simon, Lee S., Mackie, Sarah L., and Hill, Catherine L.
- Subjects
Rheumatology ,Immunology ,Immunology and Allergy - Abstract
OBJECTIVE: To survey participants with polymyalgia rheumatica (PMR) to evaluate the face validity, acceptability, and domain match of proposed candidate outcome measures. METHODS: A structured, online, anonymous survey was disseminated by patient support groups through their networks and online forums. The candidate outcome measures comprised (1) visual analog scale (VAS) and numerical rating score (NRS) to assess pain; (2) VAS, NRS, and duration to assess stiffness; (3) the modified Health Assessment Questionnaire and Health Assessment Questionnaire Disability Index to assess physical function; and (4) C-reactive protein and erythrocyte sedimentation rate to assess inflammation. Free-text answers were analyzed using descriptive thematic analysis to determine respondents' views of the candidate instruments. RESULTS: Seventy-eight people with PMR from 6 countries (UK, France, USA, Canada, Australia, and New Zealand) participated in the survey. Most respondents agreed candidate instruments were acceptable or "good to go." Free-text analysis identified 5 themes that participants considered inadequately covered by the proposed instruments. These related to (1) the variability, context, and location of pain; (2) the variability of stiffness; (3) fatigue; (4) disability; and (5) the correlation of inflammatory marker levels and severity of symptoms, sometimes reflecting disease activity and other times not. CONCLUSION: Participants reported additional aspects of their experience that are not covered by the proposed instruments, particularly for the experience of stiffness and effect of fatigue. New patient-reported outcome measures are required to increase the relevance of results from clinical trials to patients with PMR.
- Published
- 2020
15. RESULTS OF A PATIENT SURVEY ON FEASIBILITY AND FACE VALIDITY OF OUTCOME MEASURES FOR INTENDED USE IN FUTURE STUDIES ENROLLING PARTICIPANTS WITH POLYMYALGIA RHEUMATICA
- Author
-
Yates, Max, Owen, Claire E., Muller, Sara, Graham, Karly, Neill, Lorna, Twohig, Helen, Boers, Maarten, Pujades-Rodriguez, Mar D. M., Goodman, Susan, Cheah, Jonathan T. L., Dejaco, Christian, Chetan Mukhtyar, Nielsen, Berit Dalsgaard, Robson, Jo, Simon, Lee S., Shae, Bev, Mackie, Sarah L., and Hill, Catherine
- Subjects
R1 ,RA - Published
- 2019
16. Outcomes Measured in Polymyalgia Rheumatica and Measurement Properties of Instruments Considered for the OMERACT Core Outcome Set: A Systematic Review.
- Author
-
Twohig, Helen, Owen, Claire, Muller, Sara, Mallen, Christian, Mitchell, Caroline, Hider, Samantha, Hill, Catherine, Shea, Beverley, Mackie, Sarah, Mallen, Christian D, and Mackie, Sarah L
- Subjects
POLYMYALGIA rheumatica ,GIANT cell arteritis ,HEALTH outcome assessment ,MEDICAL research ,RHEUMATISM ,PAIN measurement ,SYSTEMATIC reviews ,VISUAL analog scale ,BLOOD sedimentation ,RESEARCH funding - Abstract
Objective: To systematically identify the outcome measures and instruments used in clinical studies of polymyalgia rheumatica (PMR) and to evaluate evidence about their measurement properties.Methods: Searches based on the MeSH term "polymyalgia rheumatica" were carried out in 5 databases. Two researchers were involved in screening, data extraction, and risk of bias assessment. Once outcomes and instruments used were identified and categorized, key instruments were selected for further review through a consensus process. Studies on measurement properties of these instruments were appraised against the COSMIN-OMERACT (COnsensus-based Standards for the selection of health Measurement Instruments-Outcome Measures in Rheumatology) checklist to determine the extent of evidence supporting their use in PMR.Results: Forty-six studies were included. In decreasing order of frequency, the most common outcomes (and instruments) used were markers of systemic inflammation [erythrocyte sedimentation rate (ESR), C-reactive protein (CRP)], pain [visual analog scale (VAS)], stiffness (duration in minutes), and physical function (elevation of upper limbs). Instruments selected for further evaluation were ESR, CRP, pain VAS, morning stiffness duration, and the Health Assessment Questionnaire. Five studies evaluated measurement properties of these instruments, but none met all of the COSMIN-OMERACT checklist criteria.Conclusion: Measurement of outcomes in studies of PMR lacks consistency. The critical patient-centered domain of physical function is poorly assessed. None of the candidate instruments considered for inclusion in the core outcome set had high-quality evidence, derived from populations with PMR, on their full range of measurement properties. Further studies are needed to determine whether these instruments are suitable for inclusion in a core outcome measurement set for PMR. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
17. Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study.
- Author
-
Yates, Max, Owen, Claire E., Muller, Sara, Graham, Karly, Neill, Lorna, Twohig, Helen, Boers, Maarten, Rodriguez, Mar Pujades, Goodman, Susan M., Cheah, Jonathan, Dejaco, Christian, Mukhtyar, Chetan, Nielsen, Berit Dalsgaard, Robson, Joanna, Simon, Lee S., Shea, Beverley, Mackie, Sarah L., Hill, Catherine L., Pujades-Rodriguez, Mar, and Goodman, Susan
- Subjects
POLYMYALGIA rheumatica ,ACCEPTABILITY (Linguistics) - Abstract
Objective: To survey participants with polymyalgia rheumatica (PMR) to evaluate the face validity, acceptability, and domain match of proposed candidate outcome measures.Methods: A structured, online, anonymous survey was disseminated by patient support groups through their networks and online forums. The candidate outcome measures comprised (1) visual analog scale (VAS) and numerical rating score (NRS) to assess pain; (2) VAS, NRS, and duration to assess stiffness; (3) the modified Health Assessment Questionnaire and Health Assessment Questionnaire Disability Index to assess physical function; and (4) C-reactive protein and erythrocyte sedimentation rate to assess inflammation. Free-text answers were analyzed using descriptive thematic analysis to determine respondents' views of the candidate instruments.Results: Seventy-eight people with PMR from 6 countries (UK, France, USA, Canada, Australia, and New Zealand) participated in the survey. Most respondents agreed candidate instruments were acceptable or "good to go." Free-text analysis identified 5 themes that participants considered inadequately covered by the proposed instruments. These related to (1) the variability, context, and location of pain; (2) the variability of stiffness; (3) fatigue; (4) disability; and (5) the correlation of inflammatory marker levels and severity of symptoms, sometimes reflecting disease activity and other times not.Conclusion: Participants reported additional aspects of their experience that are not covered by the proposed instruments, particularly for the experience of stiffness and effect of fatigue. New patient-reported outcome measures are required to increase the relevance of results from clinical trials to patients with PMR. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
18. Response to diagnosis of pre-diabetes in socioeconomically deprived areas: a qualitative study.
- Author
-
Twohig, Helen, Hodges, Victoria, Hobbis, Chloe, and Mitchell, Caroline
- Subjects
DIAGNOSIS of diabetes ,PREDIABETIC state ,DIABETES prevention ,SOCIOECONOMICS ,HEALTH policy ,LIFESTYLES & health - Abstract
Background: Diabetes prevention is a key priority for the NHS, with a particular focus on populations at highest risk. The NHS Diabetes Prevention Programme (NHS DPP) has been introduced, offering a course of dietary and lifestyle education to individuals with pre-diabetes. However, concerns about the NHS DPP include: (1) the possible unintended consequences of labelling more people with a 'pre-condition'; (2) the possibility of worsening health inequalities as people in socioeconomically deprived areas tend to access behaviour-change programmes less readily; (3) the appropriateness of an intervention focused on individuals versus population-wide public health policy interventions. Aim: To explore the experience of diagnosis of pre-diabetes, and understand the barriers and facilitators to uptake of the NHS DPP for people living in socioeconomically deprived areas. Design & setting: A qualitative study was undertaken. Participants with pre-diabetes were recruited from practices serving socioeconomically deprived areas of Sheffield, UK. Method: Semi-structured interviews were conducted and continued until data saturation (23 participants). Thematic analysis of data was undertaken. Results: Both healthcare context and an individual's personal and community context shaped response to diagnosis and likelihood of engaging with the NHS DPP. Patient activation was a useful concept in understanding response. Whether or not people participated in the NHS DPP, being diagnosed with pre-diabetes tended to provoke some degree of dietary change and did not cause significant anxiety for most. However, there were multiple barriers to engaging with the NHS DPP for this patient group. Conclusion: Diagnosing pre-diabetes can provoke an individual positive response, but the sociocultural environment often limits an individual's ability to engage with the NHS DPP or make lifestyle change. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
19. Toward a Core Outcome Measurement Set for Polymyalgia Rheumatica: Report from the OMERACT 2018 Special Interest Group.
- Author
-
Owen, Claire E., Yates, Max, Twohig, Helen, Muller, Sara, Neill, Lorna M., Harrison, Eileen, Shea, Beverley, Simon, Lee S., Hill, Catherine L., and Mackie, Sarah L.
- Abstract
Objective: To report the progress of the Outcome Measures in Rheumatology (OMERACT) Polymyalgia Rheumatica (PMR) Working Group in selecting candidate instruments for a core outcome measurement set.Methods: A systematic literature review identified outcomes measured and instruments used in PMR studies, and a respondent survey and raw data analysis assessed their domain match and feasibility.Results: Candidate instruments were identified for pain [visual analog scale/numerical rating scale (VAS/NRS)], stiffness (VAS/NRS and duration), and physical function (Health Assessment Questionnaire-Disability Index/modified Health Assessment Questionnaire). Domain match and feasibility assessments were favorable; however, validation in PMR was lacking.Conclusion: Further assessment of candidate instruments is required prior to recommending a PMR core outcome measurement set. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
20. Getting it right for polymyalgia rheumatica.
- Author
-
Mukhtyar, Chetan B, Twohig, Helen, and Hodgson, Humphrey
- Subjects
- *
GLUCOCORTICOIDS , *DIFFERENTIAL diagnosis , *GIANT cell arteritis , *PRIMARY health care , *POLYMYALGIA rheumatica , *ROUTINE diagnostic tests , *SECONDARY care (Medicine) ,THERAPEUTIC use of glucocorticoids - Abstract
The article discusses the recommended diagnosis and care of polymyalgia rheumatica (PMR) in primary settings except in complex cases. Topics covered include conditions mimicking PMR that contain risks, variability of PMR in primary care, and the healthcare costs of misdiagnosis and the burden of glucocorticoids. Also noted is the need to develop pathways to assist people with suspected PMR, balanced between musculoskeletal symptoms, and glucocorticoid toxicity.
- Published
- 2022
- Full Text
- View/download PDF
21. The OMERACT Core Domain Set for Outcome Measures for Clinical Trials in Polymyalgia Rheumatica.
- Author
-
Mackie, Sarah L., Twohig, Helen, Neill, Lorna M., Harrison, Eileen, Shea, Beverley, Black, Rachel J., Kermani, Tanaz A., Merkel, Peter A., Mallen, Christian D., Buttgereit, Frank, Mukhtyar, Chetan, Simon, Lee S., Hill, Catherine L., and OMERACT PMR Working Group
- Published
- 2017
- Full Text
- View/download PDF
22. Chlamydia trachomatis infection.
- Author
-
Twohig, Helen
- Subjects
CHLAMYDIA trachomatis ,SEXUALLY transmitted diseases ,BACTERIOLOGY ,CHLAMYDIA ,SYMPTOMS - Abstract
The article offers information on chlamydia trachomatis, which is regarded as the most common sexually transmitted infection in developed countries. Topics include bacteriology of chlamydia, clinical presentation of patients with chlamydia infection, and complications associated with chlamydia. The need to offer testing to anyone with symptoms suggestive of infection is mentioned.
- Published
- 2013
- Full Text
- View/download PDF
23. Talking to patients about the climate emergency.
- Author
-
Harvey, Guy, Tomson, Mike, Cussans, Amelia, Twohig, Helen, and Wilson, Angela
- Subjects
MENTAL health ,ECOLOGY ,NATIONAL health services ,PATIENTS' attitudes ,COMMUNICATION ,HEALTH ,INFORMATION resources ,CLIMATE change - Published
- 2021
24. Pre-diabetes: opportunity or overdiagnosis?
- Author
-
Twohig, Helen, Hodges, Victoria, and Mitchell, Caroline
- Subjects
PREDIABETIC state ,HEALTH policy ,MEDICAL terminology ,GLUCOSE tolerance tests ,BLOOD sugar monitoring - Abstract
An editorial is presented on the meaning of the medical term pre-diabetes along with the controversies that surround the term and its implications on the medical practice, policies and research across Great Britain. It mentions the use of the term to encompass those who are identified as high risk of diabetes through oral glucose tolerance test or fasting glucose. Also emphasized is the relevance of integrated primary care in reducing the incidence of diabetes.
- Published
- 2018
- Full Text
- View/download PDF
25. 217 Results of a patient survey on feasibility and face validity of outcome measures for intended use in future studies enrolling participants with polymyalgia rheumatica.
- Author
-
Yates, Max, Owen, Claire E, Muller, Sara, Graham, Karly, Neill, Lorna, Twohig, Helen, Boers, Maarten, Pujades-Rodriguez, Mar D M, Goodman, Susan, Cheah, Jonathan T L, Dejaco, Christian, Mukhtyar, Chetan, Nielsen, Berit Dalsgaard, Robson, Jo, Simon, Lee S, Shae, Bev, Mackie, Sarah L, and Hill, Catherine
- Subjects
CONFERENCES & conventions ,TEST validity ,EXPERIENCE ,POLYMYALGIA rheumatica - Published
- 2019
- Full Text
- View/download PDF
26. Chronic kidney disease in elderly people : disease or disease label?
- Author
-
Ellam, Timothy, Twohig, Helen, and Khwaja, Arif
27. The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope.
- Author
-
Mercer L, Abhishek A, Kavirayani A, Ahmed A, Davidson A, Foulkes A, Jones C, Nash C, Rose-Parfitt E, Dhillon E, Zabate G, Twohig H, De Vere H, Scott J, Reynolds J, Holmes J, Hartley K, Warrier K, Nowak K, Parsons K, Bechman K, Bray L, Adikari M, Wood N, Faithfull N, Gullick N, Saha P, Heaton R, Deepak S, Hider S, Khalid S, Said SS, Ryan S, Kyle S, Raghuvanshi S, Tan SY, Shivamurthy V, and Galloway J
- Abstract
This guideline will provide up-to-date, evidence-based recommendations on the safe use of non-biologic DMARDs, also called conventional synthetic DMARDs (csDMARD), across the full spectrum of autoimmune rheumatic diseases. The guideline will update the guideline published in 2017 and will be expanded to include people of all ages. Updated information on the monitoring of DMARDs and vaccinations will be included. The guideline will be developed using the methods and processes described in the British Society for Rheumatology's 'Creating clinical guidelines: our protocol', updated 2023., (© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology.)
- Published
- 2024
- Full Text
- View/download PDF
28. Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: An observational study using primary care electronic health record data.
- Author
-
Scott IC, Whittle R, Bailey J, Twohig H, Hider SL, Mallen CD, Muller S, and Jordan KP
- Abstract
Background: Contemporary data on rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritits (SpA) epidemiology in England are lacking. This knowledge is crucial to planning healthcare services. We updated algorithms defining patients with diagnoses of RA, PsA, and axial SpA in primary care and applied them to describe their incidence and prevalence in the Clinical Practice Research Datalink Aurum, an electronic health record (EHR) database covering ∼20% of England., Methods: Algorithms for ascertaining patients with RA, axial SpA, and PsA diagnoses validated in primary care EHR databases using Read codes were updated (to account for the English NHS change to SNOMED CT diagnosis coding) and applied. Updated diagnosis and synthetic disease-modifying anti-rheumatic drug code lists were devised by rheumatologists and general practitioners. Annual incidence/point-prevalence of RA, PsA, and axial SpA diagnoses were calculated from 2004 to 2020 and stratified by age/sex., Findings: Point-prevalence of RA/PsA diagnoses increased annually, peaking in 2019 (RA 0·779% [95% confidence interval (CI) 0·773, 0·784]; PsA 0·287% [95% CI 0·284, 0·291]) then falling slightly. Point-prevalence of axial SpA diagnoses increased annually (except in 2018/2019), peaking in 2020 (0·113% [95% CI 0·111, 0·115]). RA diagnosis annual incidence was higher between 2013-2019 (after inclusion in the Quality and Outcomes Framework, range 49·1 [95% CI 47·7, 50·5] to 52·1 [95% CI 50·6, 53·6]/100,000 person-years) than 2004-2012 (range 34·5 [95% CI 33·2, 35·7] to 40·0 [95% CI 38·6, 41·4]/100,000 person-years). Increases in the annual incidence of PsA/axial SpA diagnosis occurred following new classification criteria publication. Annual incidence of RA, PsA and axial SpA diagnoses fell by 40·1%, 67·4%, and 38·1%, respectively between 2019 and 2020, likely reflecting the COVID-19 pandemic's impact on their diagnosis., Interpretation: Recorded RA, PsA, and axial SpA diagnoses are increasingly prevalent in England, underlining the importance of organising healthcare services to provide timely, treat-to-target care to optimise the health of >1% of adults in England., Funding: National Institute for Health and Care Research (NIHR300826)., Competing Interests: Relevant to the present manuscript: access to CPRD data and ICS's salary was funded by an NIHR Advanced Research Fellowship award; CDM's salary is funded by the NIHR School for Primary Care Research and NIHR Applied Research Collaboration; KPJ's salary is partly funded by the NIHR Applied Research Collaboration; SM's salary is partly funded by the NIHR Applied Research Collaboration. In the last three years: ICS has received grant funding from the British Society for Rheumatology and received support for attendance at a conference from the NIHR; Keele University have received funding for CDM's salary from the MRC, AHRC, Versus Arthritis, NIHR, and BMS., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
29. Primary care for people with severe mental illness and comorbid obstructive airways disease: a qualitative study of patient perspectives with integrated stakeholder feedback.
- Author
-
Mitchell C, Zuraw N, Delaney B, Twohig H, Dolan N, Walton E, Hulin J, and Yousefpour C
- Subjects
- Feedback, Humans, Primary Health Care, Asthma epidemiology, Asthma therapy, Mental Disorders complications, Mental Disorders epidemiology, Mental Disorders therapy, Pulmonary Disease, Chronic Obstructive epidemiology, Pulmonary Disease, Chronic Obstructive therapy
- Abstract
Objectives: To explore patient and stakeholder perspectives on primary respiratory care for people with severe mental illness (SMI) and comorbid obstructive airways disease (OAD)., Design: Qualitative, semistructured qualitative interviews were undertaken with a purposive sample of people with a diagnosis of SMI (bipolar illness, schizophrenia, affective disorder with psychosis) and comorbid asthma or chronic obstructive pulmonary disease. Transcribed data were analysed using an interpretive phenomenological approach. Study results were discussed with stakeholders., Setting: Eight UK general practices., Participants: 16 people aged 45-75 years, with SMI and comorbid asthma or chronic obstructive pulmonary disease, were interviewed. Twenty-one people, four with lived experience of SMI and seventeen health/social care/third sector practitioners, participated in discussion groups at a stakeholder event., Results: Participants described disability and isolation arising from the interplay of SMI and OAD symptoms. Social support determined ease of access to primary care. Self-management of respiratory health was not person-centred as practitioners failed to consider individual needs and health literacy. Participants perceived smoking cessation impossible without tailored support. Less than half of the practices facilitated personalised access to timely primary care and continuity. Overall, there was a reliance on urgent care if service adaptations and social support were lacking. The stakeholder group expressed concern about gaps in care, the short-term funding of community organisations and fear of loss of benefits. Potential solutions focused on supported navigation of care pathways, relational continuity, individual and community asset building and the evolving social prescriber role., Conclusion: This study suggests that despite UK guidelines and incentives to optimise physical healthcare, primary care fails to consistently deliver integrated biopsychosocial care for patients with SMI and OAD. Collaborative, personalised care that builds social capital and tailors support for self-management is needed, alongside service-level interventions to enhance access to healthcare for patients with comorbid SMI and OAD., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
30. Assessment of the face validity, feasibility and utility of a patient-completed questionnaire for polymyalgia rheumatica: a postal survey using the QQ-10 questionnaire.
- Author
-
Twohig H, Jones G, Mackie S, Mallen C, and Mitchell C
- Abstract
Background: The development of a patient-reported outcome measure (PROM) for polymyalgia rheumatica (PMR), a condition that causes pain, stiffness and disability, is necessary as there is no current validated disease-specific measure. Initial literature synthesis and qualitative research established a conceptual framework for the condition along with a list of symptoms and effects of PMR that patients felt were important to them. These findings were used to derive the candidate items for a patient-completed questionnaire. We aim to establish the face validity of this initial "long form" of a PROM., Methods: People with a current or previous diagnosis of PMR were recruited both from the community and from rheumatology clinics. They were asked to complete the PMR questionnaire along with the QQ-10 questionnaire, which is a measure used to assess the face validity, feasibility and utility of patient healthcare questionnaires., Results: A total of 28 participants with an age range of 59-85 years and a length of time since diagnosis from 4 months to 18 years completed the QQ-10. The overall mean "value" score was 79% (SD 12), and the mean "burden" score was 21% (SD 18). The free-text comments were analysed thematically and were found to focus on layout, content, where in the clinical pathway the questionnaire would be most beneficial, specific items missing and other areas for consideration., Conclusions: The high mean value score and low burden score indicate that the questionnaire has good face validity and is acceptable to patients. The questionnaire now needs to undergo further psychometric evaluation and refinement to develop the final tool for use in clinical practice and research.
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.